Latest Breaking News On - Dose inhalers - Page 1 : vimarsana.com

Sunshine Holdings healthcare arm woos IFC to take up 14 7% stake for Rs 3 27 b

Sunshine Holdings healthcare arm woos IFC to take up 14 7% stake for Rs 3 27 b
ft.lk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ft.lk Daily Mail and Mail on Sunday newspapers.

Sri lankaSri lankansAsia pacific riccardo pulitiAsia imad fakhouryVictor antonypillaiShyam sathasivamHiran samarasinghePacific riccardo pulitiAruna deepthikumaraPriyanka cooraySunshine holdingInternational finance corporationSunshine holdingsSunshine holdings groupSunshine holdings deputy viceGroup legal consultant roshani kobbekaduwa

IFC Set to Invest Up to LKR 3,270 million in Sunshine Healthcare Lanka Limited - Adaderana Biz English

IFC Set to Invest Up to LKR 3,270 million in Sunshine Healthcare Lanka Limited - Adaderana Biz English
bizenglish.adaderana.lk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizenglish.adaderana.lk Daily Mail and Mail on Sunday newspapers.

Sri lankaSri lankansShyam sathasivamRoshani kobbekaduwaAruna deepthikumaraRiccardo pulitiHiran samarasingheGroup legalSunshine holdingsPharmaceuticals distributionSunshine holdingInternational finance corporationSunshine healthcare lankaLina manufacturingDose inhalersMedical devices

IFC to invest Rs 3,270Mn in Sunshine Healthcare Lanka Ltd

IFC to invest Rs 3,270Mn in Sunshine Healthcare Lanka Ltd
lankabusinessonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lankabusinessonline.com Daily Mail and Mail on Sunday newspapers.

Sri lankaSri lankansHiran samarasingheAruna deepthikumaraRiccardo pulitiRoshani kobbekaduwaShyam sathasivamSunshine holdingPharmaceuticals distributionGroup legalInternational finance corporationSunshine holdingsSunshine healthcare lankaLina manufacturingDose inhalersMedical devices

Respiratory Drug Delivery Market Report 2024-2034

Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) The

South africaSouth koreaNew zealandUnited statesUnited kingdomKoninklijke philipsMedisana gmbCipla incPropeller healthGf health products incSumitomo pharma co ltdGlenmark pharmaceuticals ltdBoehringer ingelheim international gmbOmron corporationAptargroup incTeva pharmaceutical industries ltd

Pulmonary Drug Delivery Devices Market to Exceed Value of USD 49 5 Billion by 2031, TMR Study

The rise in the prevalence of major respiratory disorders is expected to drive the pulmonary drug delivery devices market during the forecast period.Wilmington, Delaware, United States, Nov. 23, 2023 (GLOBE NEWSWIRE) Transparency Market Research Inc. -The global pulmonary drug delivery devices market is projected to flourish at a CAGR of 4.7% from 2022 to 2031. As per the report published by TMR, a valuation of US$ 49.5 billion is anticipated for the market in 2031. As of 2023, the demand for

United statesNikhil sawlaniBoehringer ingelheim gmbAsia pacificChiesi farmaceuticiKoninklijke philipsTeva pharmaceutical industries ltdAsk expert for the researchSunovion pharmaceuticals incBoehringer ingelheimMerck coTransparency market researchOmron corporationTransparency market research incMannkind corporationJabil circuit inc